scispace - formally typeset
Search or ask a question
Institution

University of Erlangen-Nuremberg

EducationErlangen, Bayern, Germany
About: University of Erlangen-Nuremberg is a education organization based out in Erlangen, Bayern, Germany. It is known for research contribution in the topics: Population & Immune system. The organization has 42405 authors who have published 85600 publications receiving 2663922 citations.


Papers
More filters
Proceedings Article
01 Jan 2011
TL;DR: The design of Kaldi is described, a free, open-source toolkit for speech recognition research that provides a speech recognition system based on finite-state automata together with detailed documentation and a comprehensive set of scripts for building complete recognition systems.
Abstract: We describe the design of Kaldi, a free, open-source toolkit for speech recognition research. Kaldi provides a speech recognition system based on finite-state automata (using the freely available OpenFst), together with detailed documentation and a comprehensive set of scripts for building complete recognition systems. Kaldi is written is C++, and the core library supports modeling of arbitrary phonetic-context sizes, acoustic modeling with subspace Gaussian mixture models (SGMM) as well as standard Gaussian mixture models, together with all commonly used linear and affine transforms. Kaldi is released under the Apache License v2.0, which is highly nonrestrictive, making it suitable for a wide community of users.

5,857 citations

Journal ArticleDOI
TL;DR: Preoperative chemoradiotherapy, as compared with postoperative cheMoradi therapy, improved local control and was associated with reduced toxicity but did not improve overall survival.
Abstract: background Postoperative chemoradiotherapy is the recommended standard therapy for patients with locally advanced rectal cancer. In recent years, encouraging results with preoperative radiotherapy have been reported. We compared preoperative chemoradiotherapy with postoperative chemoradiotherapy for locally advanced rectal cancer. methods We randomly assigned patients with clinical stage T3 or T4 or node-positive disease to receive either preoperative or postoperative chemoradiotherapy. The preoperative treatment consisted of 5040 cGy delivered in fractions of 180 cGy per day, five days per week, and fluorouracil, given in a 120-hour continuous intravenous infusion at a dose of 1000 mg per square meter of body-surface area per day during the first and fifth weeks of radiotherapy. Surgery was performed six weeks after the completion of chemoradiotherapy. One month after surgery, four five-day cycles of fluorouracil (500 mg per square meter per day) were given. Chemoradiotherapy was identical in the postoperative-treatment group, except for the delivery of a boost of 540 cGy. The primary end point was overall survival. results Four hundred twenty-one patients were randomly assigned to receive preoperative chemoradiotherapy and 402 patients to receive postoperative chemoradiotherapy. The overall five-year survival rates were 76 percent and 74 percent, respectively (P=0.80). The five-year cumulative incidence of local relapse was 6 percent for patients assigned to preoperative chemoradiotherapy and 13 percent in the postoperative-treatment group (P=0.006). Grade 3 or 4 acute toxic effects occurred in 27 percent of the patients in the preoperative-treatment group, as compared with 40 percent of the patients in the postoperative-treatment group (P=0.001); the corresponding rates of long-term toxic effects were 14 percent and 24 percent, respectively (P=0.01). conclusions Preoperative chemoradiotherapy, as compared with postoperative chemoradiotherapy, improved local control and was associated with reduced toxicity but did not improve overall survival.

5,218 citations

Journal ArticleDOI
Daniel J. Klionsky1, Kotb Abdelmohsen2, Akihisa Abe3, Joynal Abedin4  +2519 moreInstitutions (695)
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Abstract: In 2008 we published the first set of guidelines for standardizing research in autophagy. Since then, research on this topic has continued to accelerate, and many new scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Accordingly, it is important to update these guidelines for monitoring autophagy in different organisms. Various reviews have described the range of assays that have been used for this purpose. Nevertheless, there continues to be confusion regarding acceptable methods to measure autophagy, especially in multicellular eukaryotes. For example, a key point that needs to be emphasized is that there is a difference between measurements that monitor the numbers or volume of autophagic elements (e.g., autophagosomes or autolysosomes) at any stage of the autophagic process versus those that measure flux through the autophagy pathway (i.e., the complete process including the amount and rate of cargo sequestered and degraded). In particular, a block in macroautophagy that results in autophagosome accumulation must be differentiated from stimuli that increase autophagic activity, defined as increased autophagy induction coupled with increased delivery to, and degradation within, lysosomes (in most higher eukaryotes and some protists such as Dictyostelium) or the vacuole (in plants and fungi). In other words, it is especially important that investigators new to the field understand that the appearance of more autophagosomes does not necessarily equate with more autophagy. In fact, in many cases, autophagosomes accumulate because of a block in trafficking to lysosomes without a concomitant change in autophagosome biogenesis, whereas an increase in autolysosomes may reflect a reduction in degradative activity. It is worth emphasizing here that lysosomal digestion is a stage of autophagy and evaluating its competence is a crucial part of the evaluation of autophagic flux, or complete autophagy. Here, we present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes. These guidelines are not meant to be a formulaic set of rules, because the appropriate assays depend in part on the question being asked and the system being used. In addition, we emphasize that no individual assay is guaranteed to be the most appropriate one in every situation, and we strongly recommend the use of multiple assays to monitor autophagy. Along these lines, because of the potential for pleiotropic effects due to blocking autophagy through genetic manipulation, it is imperative to target by gene knockout or RNA interference more than one autophagy-related protein. In addition, some individual Atg proteins, or groups of proteins, are involved in other cellular pathways implying that not all Atg proteins can be used as a specific marker for an autophagic process. In these guidelines, we consider these various methods of assessing autophagy and what information can, or cannot, be obtained from them. Finally, by discussing the merits and limits of particular assays, we hope to encourage technical innovation in the field.

5,187 citations

Journal ArticleDOI
TL;DR: The use of absolute magnetic shieldings, computed at ring centers with available quantum mechanics programs, are proposed as a new aromaticity/antiaromaticity criterion to establish NICS as an effective aromaticity criterion.
Abstract: The ability to sustain a diatropic ring current is the defining characteristic of aromatic species.1-7 Cyclic electron delocalization results in enhanced stability, bond length equalization, and special magnetic as well as chemical and physical properties.1 In contrast, antiaromatic compounds sustain paratropic ring currents3 despite their localized, destabilized structures.1-7 We have demonstrated the direct, quantitative relationships among energetic, geometrical, and magnetic criteria of aromaticity in a wide-ranging set of aromatic/antiaromatic fivemembered rings.5a While the diamagnetic susceptibility exaltation (Λ) is uniquely associated with aromaticity, it is highly dependent on the ring size (area2) and requires suitable calibration standards.6 Aromatic stabilization energies (ASEs) of strained and more complicated systems are difficult to evaluate. CC bond length variations in polybenzenoid hydrocarbons can be just as large as those in linear conjugated polyenes.2 The abnormal proton chemical shifts of aromatic molecules are the most commonly employed indicators of ring current effects.1 However, the ca. 2-4 ppm displacements of external protons to lower magnetic fields are relatively modest (e.g., δH ) 7.3 for benzene vs 5.6 for dC-H in cyclohexene). In contrast, the upfield chemical shifts of protons located inside aromatic rings are more unusual. The six inner hydrogens of [18]annulene, for example, resonate at -3.0 ppm vs δ ) 9.28 for the outer protons. This relationship is inverted dramatically in the antiaromatic [18]annulene dianion, C18H18, where δ ) 20.8 and 29.5 (in) vs. -1.1 (out).8 Similar demonstrations of paratropic ring currents in antiaromatic compounds are well documented.3,8,9 Chemical shifts of encapsulated 3He atoms are now employed as experimental and computed measures of aromaticity in fullerenes and fullerene derivatives.10 While the rings of most aromatic systems are too small to accommodate atoms internally, the chemical shifts of hydrogens in bridging positions have long been used as aromaticity and antiaromaticity probes.9 δLi+ can be employed similarly, with the advantage that Li+ complexes with individual rings in polycyclic systems can be computed.4,11 We now propose the use of absolute magnetic shieldings, computed at ring centers (nonweighted mean of the heavy atom coordinates) with available quantum mechanics programs,12 as a new aromaticity/antiaromaticity criterion. To correspond to the familiar NMR chemical shift convention, the signs of the computed values are reversed: Negative “nucleus-independent chemical shifts” (NICSs) denote aromaticity; positive NICSs, antiaromaticity (see Table 1 for selected results). Figure 1, a plot of NICSs vs the ASEs for our set of five-membered ring heterocycles,5a provides calibration. The equally good correlations with magnetic susceptibility exaltations and with structural variations establish NICS as an effective aromaticity criterion. Unlike Λ,6 NICS values for [n]annulenes (Table 1) show only a modest dependence on ring size. The 10 π electron systems give significantly higher values than those with 6 π electrons. The antiaromatic 4n π electron compounds, cyclobutadiene (27.6), pentalene (18.1), heptalene (22.7), and planar D4h cyclooctatetraene (30.1), all show highly positive NICSs. Like the Li+-complex probe,4 the NICS evaluates the aromaticity and antiaromaticity contributions of individual rings in polycyclic systems. Scheme 1 (HF/6-31+G*, data from Table 1) shows NICSs for selected examples. The benzenoid aromatic NICSs provide evidence both for localized and “perimeter” models. The naphthalene (1) NICS (-9.9) resembles that of benzene (-9.7), as do the NICSs for the outer rings of phenanthrene (2) (-10.2) and triphenylene (3); the aromaticity of the central rings of the latter two are reduced. The NICS of the central ring of anthracene (4) (-13.3) exceeds the benzene value in contrast to the outer ring NICS (-8.2). Remarkably, the NICS (-7.0) for the seven-membered ring of azulene (5) is very close to that of the tropylium ion (-7.6 ppm), whereas the azulene five-membered ring NICS (-19.7) is even larger in magnitude than that of the cyclopentadienyl anion (-14.3). The four-membered rings in benzocyclobutadiene (6) (NICS ) 22.5) and in biphenylene (7) (19.0) are antiaromatic, but less so than cyclobutadiene itself (27.6). The six-membered rings in these polycycles are still aromatic, but their NICSs (-2.5 (1) (a) Minkin, V. I.; Glukhovtsev, M. N.; Simkin, B. Y. Aromaticity and Antiaromaticity; Wiley: New York, 1994. (b) Garratt, P. J. Aromaticity; Wiley: New York, 1986. (c) Eluidge, J. A.; Jackman, L. M. J. Chem. Soc. 1961, 859. (2) Schleyer, P. v. R.; Jiao, H. Pure Appl. Chem. 1996, 28, 209. (3) Pople, J. A.; Untch, K. G. J. Am. Chem. Soc. 1966, 88, 4811. (4) Jiao, H; Schleyer, P. v. R. AIP Conference Proceedings 330, E.C.C.C.1, Computational Chemistry; Bernardi, F., Rivail, J.-L., Eds.; American Institute of Physics: Woodbury, New York, 1995; p 107. (5) (a) Schleyer, P. v. R.; Freeman, P.; Jiao, H.; Goldfuss, B. Angew. Chem., Int. Ed. Engl. 1995, 34, 337. (b) Jiao, H.; Schleyer, P. v. R. Unpublished IGLO results. (c) Kutzelnigg, W.; Fleischer, U.; Schindler, M. In NMR: Basic Princ. Prog.; Springer: Berlin, 1990; Vol. 23, p 165. (6) Dauben, H. J., Jr.; Wilson, J. D.; Laity, J. L. In Non-Benzenoid Aromatics; Synder, J., Ed.; Academic Press, 1971; Vol. 2, and references cited. The partitioning of ring current or ring current susceptabilitites among various rings in polycyclic syestems were considered earlier, e.g., by Aihara (Aihara, J. J. Am. Chem. Soc. 1985, 207, 298 and refs cited) and by Mallion (Haigh, C. W.; Mallion, J. Chem. Phys. 1982, 76, 1982). (7) Fleischer, U.; Kutzelnigg, W.; Lazzeretti, P.; Mühlenkamp, V. J. Am. Chem. Soc. 1994, 116, 5298. (8) Sondheimer, F. Acc. Chem. Res. 1972, 5, 81. (9) (a) Hunandi, R. J. J. Am. Chem. Soc. 1983, 105, 6889. (b) Pascal, R. A., Jr.; Winans, C. G.; Van Engen, D. J. Am. Chem. Soc. 1989, 111, 3007. (10) (a) Bühl, M.; Thiel, W.; Jiao, H.; Schleyer, P. v. R.; Saunders, M.; Anet, F. A. L. J. Am. Chem. Soc. 1994, 116, 7429 and references cited. (b) Bühl, M.; van Wüllen, C. Chem. Phys. Lett. 1995, 247, 63. The authors have shown that the negative absolute shielding in the center of C60 is nearly the same as δ3He, computed at the same level. (11) Paquette, L. A.; Bauer, W.; Sivik, M. R.; Bühl, M.; Feigel, M.; Schleyer, P. v. R. J. Am. Chem. Soc. 1990, 112, 8776. (12) Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Gill, P. M. W.; Johnson, B. G.; Robb, M. A.; Cheeseman, J. R.; Keith, T. A.; Petersson, G. A.; Montgomery, J. A.; Raghavachari, K.; Al-Laham, M. A.; Zakrewski, V. G.; Ortiz, J. V.; Foresman, J. B.; Cioslowski, J.; Stefanov, B. B.; Nanayakkara, A.; Challacombe, M.; Peng, C. Y.; Ayala, P. Y.; Chen, W.; Wong, M. W.; Andres, J. L.; Replogle, E. S.; Gomperts, R.; Stewart, J. P.; Head-Gordon, M.; Gonzalez, C.; Pople, J. A. Gaussian 94, ReVision B.2; Gaussian Inc., Pittsburgh, PA, 1995. Figure 1. Plot of NICSs (ppm) vs the aromatic stabilization energies (ASEs, kcal/mol)5a for a set of five-membered ring heterocycles, C4H4X (X ) as shown) (cc ) 0.966). 6317 J. Am. Chem. Soc. 1996, 118, 6317

4,921 citations

Journal ArticleDOI
TL;DR: In the time-to-event analysis, the rate of the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, orNonfatal stroke among patients with type 2 diabetes mellitus was lower with liraglutide than with placebo.
Abstract: BackgroundThe cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients with type 2 diabetes, remains unknown. MethodsIn this double-blind trial, we randomly assigned patients with type 2 diabetes and high cardiovascular risk to receive liraglutide or placebo. The primary composite outcome in the time-to-event analysis was the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. The primary hypothesis was that liraglutide would be noninferior to placebo with regard to the primary outcome, with a margin of 1.30 for the upper boundary of the 95% confidence interval of the hazard ratio. No adjustments for multiplicity were performed for the prespecified exploratory outcomes. ResultsA total of 9340 patients underwent randomization. The median follow-up was 3.8 years. The primary outcome occurred in significantly fewer patients in the liraglutide group (608 of 4668 patients [13.0%]) than in the placebo ...

4,409 citations


Authors

Showing all 42831 results

NameH-indexPapersCitations
Hermann Brenner1511765145655
Richard B. Devereux144962116403
Manfred Paulini1411791110930
Daniel S. Berman141136386136
Peter Lang140113698592
Joseph Sodroski13854277070
Richard J. Johnson13788072201
Jun Lu135152699767
Michael Schmitt1342007114667
Jost B. Jonas1321158166510
Andreas Mussgiller127105973778
Matthew J. Budoff125144968115
Stefan Funk12550656955
Markus F. Neurath12493462376
Jean-Marie Lehn123105484616
Network Information
Related Institutions (5)
Technische Universität München
123.4K papers, 4M citations

96% related

Ludwig Maximilian University of Munich
161.5K papers, 5.7M citations

95% related

Heidelberg University
119.1K papers, 4.6M citations

94% related

National University of Singapore
165.4K papers, 5.4M citations

93% related

University of Padua
114.8K papers, 3.6M citations

93% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023208
2022660
20215,162
20204,911
20194,593
20184,374